Health · Science · Policy

GLP-1 and obesity drugs

Supply, trials, pricing and competition in obesity treatment.

Follow Ask about this

Daily activity

Developing

Oct 7 · 1

Oct 31Oct 7

Signals in this topic

01WHO recommends lifestyle changes over GLP-1 drugs for child obesityThe World Health Organization endorsed diet, exercise, and counseling over weight-loss drugs for younger children, citing safety and long-term effectiveness concerns. GLP-1 drugs may be considered for adolescents aged 10 to 19 after supervised interventions fail.New primary claim2026-10-07 16:15